Avadel Pharmaceuticals plc Overview

Avadel Pharmaceuticals plc EBIT

EBIT (Earnings Before Interest and Taxes) analysis for AVDL.

Quarterly EBIT

$2.47M

↑ 855.05% YoY

As of Sep 30, 2025

Annual EBIT (TTM)

$6.06M

↑ 109.46% YoY

Trailing 12 months ending Sep 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin